General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0PCGKN
ADC Name
hu5B1-TCO
Synonyms
hu5B1 TCO
   Click to Show/Hide
Organization
Memorial Sloan Kettering Cancer Center
Drug Status
Phase 1
Indication
In total 1 Indication(s)
Pancreatic cancer [ICD11:2C10]
Investigative
Antibody Name
Undisclosed
Antigen Name
Undisclosed
Payload Name
Undisclosed
Linker Name
Undisclosed

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.